First-ever cancer prevention research meeting

October 14, 2002

Boston, MA (October 14, 2002) - Scientists from around the world are convening here this week at the first-ever annual meeting, organized by the American Association for Cancer Research, dedicated solely to new research in cancer prevention.

Frontiers in Cancer Prevention Research, taking place October 14-18, 2002, will focus on new studies describing how early intervention through novel preventive drugs, screening methods, diet and lifestyle, and surgical techniques may stop cancer before it has a chance to begin.

"Standard screenings, such as Pap smear for cervical cancer and colonoscopy for colorectal cancer, may soon be joined by a host of new screening methods, such as examination of exfoliated skin cells, patterns of protein in the blood, and nipple aspiration and ductal lavage," said Waun Ki Hong, M.D., the American Cancer Society Professor and Charles A. LeMaistre Distinguished Chair in Thoracic Oncology with the University of Texas M.D. Anderson Cancer Center, Houston, and meeting chairperson.

Developing novel drug therapies requires the identification of new drug targets, routes of administration, and approaches including gene therapy. Research into targeted therapies is yielding new advances in the way drugs are developed and used, and has begun to close the gap between therapy and prevention. For instance, tamoxifen, which originally was developed to treat breast cancer, is now proven to be effective in reducing the risk of cancer in high-risk patients.

More than a half a million people will die from cancer in 2002. It is the second leading cause of death in the United States, after heart disease. AACR leaders envision a future where, through research, the suffering of millions of people worldwide will be alleviated through new prevention techniques.

"We believe that in the future we will be able to treat cancer similar to how cardiologists are treating heart disease. Through the use of preventive medications and life-style modifications, cardiology has moved beyond treating major cardiovascular disease events to identifying and treating the risk factors, such as elevated blood pressure," says Susan Band Horwitz, Ph.D., president of AACR, and the Falkenstein Professor of Cancer Research and co-chair of the Department of Molecular Pharmacology, Albert Einstein College of Medicine, New York.

Some of the recent findings to be presented at the meeting include:
Advances in Breast Cancer Prevention:
· Use of a selective COX-2 inhibitor (celecoxib) as potential target for preventing and possibly treating breast cancer.
· Short-term use of pregnancy-level estrogen as protection from chemical-induced breast cancer.
Relationship Between Obesity, Calories and Cancer Prevention:
· Prepubertal diet affecting future breast cancer risk.
· Diet and exercise to minimize side effects from chemopreventive agents.
New Research in Novel Therapies and Cancer Prevention:
· Telomere shortening as an early and prevalent marker of the cancer process in several malignancies. · Genetic testing to help drive people to be screened for colorectal cancer.

"Despite the substantial progress in cancer prevention, there are still many obstacles to overcome," explains Dr. Hong. "Future prevention research should increasingly integrate genomic studies with studies of environmental factors, lifestyle and diet. We need to determine why some agents have preventive qualities in one organ, yet seem to stimulate cancer growth in another. There is still much to be learned."

Some 1,000 scientists, oncology experts and others interested in cancer prevention are attending Frontiers in Cancer Prevention Research.
-end-
Founded in 1907, the American Association for Cancer Research (AACR) is a professional society of more than 19,000 laboratory and clinical scientists engaged in cancer research in the United States in more than 60 other countries. AACR's mission is to accelerate the prevention and cure of cancer through research, education, communication and advocacy. Its principal activities include the publication of five major peer-reviewed scientific journals (Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Epidemiology, Biomarkers & Prevention).

American Association for Cancer Research

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.